申基生物成立于2018年，專注于為客戶提供生命科學領域上游原料的整體解決方案。公司多年來致力于生命科學卡脖子原料的研發和產業化，現已具有抗體發現平臺、mRNA原液制備平臺、mRNA-LNP制劑工藝平臺、寡核苷酸制備平臺、酶定向進化平臺等技術，在此驅動下，衍生細胞基因治療原料、基因核酸藥物原料以及IVD原料三大產品板塊。
?
Founded in 2018, Jiangsu Synthgene Biotechnology Co., Ltd. focuses on providing overall solutions for upstream raw materials in life sciences. Over the years, Synthgene is committed to the development and industrialization of life science insurmountable raw materials. Currently, Synthgene antibody discovery platform, mRNA stock solution preparation platform, mRNA-LNP preparation process platform, oligonucleotide preparation platform, enzyme directed evolution platform contribute to derivative three product segments include cell gene therapy raw materials, gene nucleic acid drug raw materials and IVD raw materials.?